Pacer Advisors Portfolio holdings
AUM
$39.6B
1-Year Return
5.04%
This Quarter Return
+10.34%
1 Year Return
+5.04%
3 Year Return
+42.86%
5 Year Return
+91.64%
10 Year Return
+332.32%
AUM
$5.32B
AUM Growth
+$623M
(+13%)
Cap. Flow
+$354M
Cap. Flow
% of AUM
6.65%
Top 10 Holdings %
Top 10 Hldgs %
31.02%
Holding
1,573
New
308
Increased
332
Reduced
859
Closed
60
Top Buys
| 1 |
Equinix
EQIX
|
+$41.9M |
| 2 |
American Tower
AMT
|
+$33.5M |
| 3 |
CD
Chindata Group Holdings Limited American Depositary Shares
CD
|
+$28M |
| 4 |
Crown Castle
CCI
|
+$20.9M |
| 5 |
CONE
CyrusOne Inc Common Stock
CONE
|
+$13.7M |
Top Sells
| 1 |
Apple
AAPL
|
+$89.3M |
| 2 |
Microsoft
MSFT
|
+$66.1M |
| 3 |
Amazon
AMZN
|
+$63.1M |
| 4 |
Meta Platforms (Facebook)
META
|
+$26.3M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$25.2M |
Sector Composition
| 1 | Real Estate | 18.33% |
| 2 | Technology | 16.47% |
| 3 | Consumer Discretionary | 8.8% |
| 4 | Healthcare | 7.69% |
| 5 | Communication Services | 7.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1126
Motorcar Parts of America
MPAA
$286M
| $173K | ﹤0.01% |
8,803
+3,225
| +58% | +$63.4K |
|
1127
Zillow
Z
$21.1B
| $172K | ﹤0.01% |
+1,322
| New | +$172K |
|
1128
Agios Pharmaceuticals
AGIO
$2.1B
| $170K | ﹤0.01% |
3,924
+1,695
| +76% | +$73.4K |
|
|
SAGE
1129
DELISTED
Sage Therapeutics
SAGE
| $169K | ﹤0.01% |
1,953
-950
| -33% | -$82.2K |
|
1130
Wayfair
W
$11.2B
| $169K | ﹤0.01% |
+748
| New | +$169K |
|
1131
HNI Corp
HNI
$2.09B
| $164K | ﹤0.01% |
4,761
-5,524
| -54% | -$190K |
|
1132
Ionis Pharmaceuticals
IONS
$10.3B
| $163K | ﹤0.01% |
2,881
+1,080
| +60% | +$61.1K |
|
1133
TG Therapeutics
TGTX
$5.08B
| $163K | ﹤0.01% |
3,130
-2,988
| -49% | -$156K |
|
1134
Urban Edge Properties
UE
$2.65B
| $160K | ﹤0.01% |
12,355
-14,378
| -54% | -$186K |
|
1135
Mercury Insurance
MCY
$4.32B
| $159K | ﹤0.01% |
3,039
-3,523
| -54% | -$184K |
|
1136
Tredegar Corp
TG
$268M
| $159K | ﹤0.01% |
+9,543
| New | +$159K |
|
1137
Fortis
FTS
$24.7B
| $157K | ﹤0.01% |
+3,843
| New | +$157K |
|
1138
Smith & Nephew
SNN
$16.8B
| $157K | ﹤0.01% |
3,726
-814
| -18% | -$34.3K |
|
|
FRGI
1139
DELISTED
Fiesta Restaurant Group, Inc.
FRGI
| $157K | ﹤0.01% |
+13,744
| New | +$157K |
|
1140
argenx
ARGX
$46.9B
| $156K | ﹤0.01% |
+530
| New | +$156K |
|
1141
Vanda Pharmaceuticals
VNDA
$266M
| $156K | ﹤0.01% |
11,884
+1,067
| +10% | +$14K |
|
1142
BridgeBio Pharma
BBIO
$10.2B
| $153K | ﹤0.01% |
2,147
-1,518
| -41% | -$108K |
|
1143
Kodiak Sciences
KOD
$531M
| $153K | ﹤0.01% |
1,039
-258
| -20% | -$38K |
|
1144
Restaurant Brands International
QSR
$20.3B
| $152K | ﹤0.01% |
+2,495
| New | +$152K |
|
1145
Apellis Pharmaceuticals
APLS
$3.39B
| $152K | ﹤0.01% |
2,655
-736
| -22% | -$42.1K |
|
1146
CGI
GIB
$21.3B
| $152K | ﹤0.01% |
+1,918
| New | +$152K |
|
|
SMAR
1147
DELISTED
Smartsheet Inc.
SMAR
| $152K | ﹤0.01% |
2,193
-478
| -18% | -$33.1K |
|
1148
Equinor
EQNR
$61.2B
| $151K | ﹤0.01% |
9,205
-158,743
| -95% | -$2.6M |
|
1149
Editas Medicine
EDIT
$248M
| $149K | ﹤0.01% |
2,132
-1,552
| -42% | -$108K |
|
1150
Nice
NICE
$8.85B
| $147K | ﹤0.01% |
520
-110
| -17% | -$31.1K |
|